Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies Assessed in a Real-World Non-Interventional Study (EUCHARIS)

NCT05043506 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05043506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05043506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies Assessed in a Real-World Non-Interventional Study (EUCHARIS)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 8, 2022
Completion date
November 2, 2023
Enrollment
1,939 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer